49 results on '"Sellers, Stephanie A."'
Search Results
2. Optimization of Enzymatic and Chemical Decellularization of Native Porcine Heart Valves for the Generation of Decellularized Xenografts.
- Author
-
Saeid Nia, Monireh, Floder, Lena Maria, Seiler, Jette Anika, Puehler, Thomas, Pommert, Nina Sophie, Berndt, Rouven, Meier, David, Sellers, Stephanie L., Sathananthan, Janarthanan, Zhang, Xiling, Hasler, Mario, Gorb, Stanislav N., Warnecke, Gregor, and Lutter, Georg
- Subjects
HEART valves ,XENOGRAFTS ,HEART valve diseases ,TRITON X-100 ,IMMUNE response ,TISSUE engineering - Abstract
One of the most important medical interventions for individuals with heart valvular disease is heart valve replacement, which is not without substantial challenges, particularly for pediatric patients. Due to their biological properties and biocompatibility, natural tissue-originated scaffolds derived from human or animal sources are one type of scaffold that is widely used in tissue engineering. However, they are known for their high potential for immunogenicity. Being free of cells and genetic material, decellularized xenografts, consequently, have low immunogenicity and, thus, are expected to be tolerated by the recipient's immune system. The scaffold ultrastructure and ECM composition can be affected by cell removal agents. Therefore, applying an appropriate method that preserves intact the structure of the ECM plays a critical role in the final result. So far, there has not been an effective decellularization technique that preserves the integrity of the heart valve's ultrastructure while securing the least amount of genetic material left. This study demonstrates a new protocol with untraceable cells and residual DNA, thereby maximally reducing any chance of immunogenicity. The mechanical and biochemical properties of the ECM resemble those of native heart valves. Results from this study strongly indicate that different critical factors, such as ionic detergent omission, the substitution of Triton X-100 with Tergitol, and using a lower concentration of trypsin and a higher concentration of DNase and RNase, play a significant role in maintaining intact the ultrastructure and function of the ECM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Tricuspid Regurgitation and TAVR: Outcomes, Risk Factors and Biomarkers.
- Author
-
Puehler, Thomas, Pommert, Nina Sophie, Freitag-Wolf, Sandra, Seoudy, Hatim, Ernst, Markus, Haneya, Assad, Sathananthan, Janarthanan, Sellers, Stephanie L., Meier, David, Schöttler, Jan, Müller, Oliver J., Salehi Ravesh, Mona, Saad, Mohammed, Frank, Derk, and Lutter, Georg
- Subjects
HEART valve prosthesis implantation ,BRAIN natriuretic factor ,MORTALITY risk factors ,TRICUSPID valve insufficiency - Abstract
Background. The significance of concomitant tricuspid regurgitation (TR) in the context of transcatheter aortic valve replacement (TAVR) remains unclear. This study aimed to analyze the severity of TR before and after TAVR with regard to short- and long-term survival and to analyze the influencing factors. Methods. In our retrospective analysis, TR before and after TAVR was examined and patients were classified into groups accordingly. Special attention was paid to patients with post-interventional changes in TR. Mortality after TAVR was considered the primary endpoint of the analysis and major complications according to the Valve Academic Research Consortium 3 (VARC3) were compared. Moreover, biomarkers and risk factors for worsening or improvement of TR through TAVR were analyzed. Results. Among 775 patients who underwent TAVR in our center between January 2009 and December 2019, 686 patients (89%) featured low- and 89 patients (11%) high-grade TR. High-grade pre-TAVR TR was associated with worse short- (30-day), mid- (2-year) and long-term survival up to 8 years. Even though in nearly half of the patients with high-grade TR the regurgitation improved within seven days after TAVR (n = 42/89), this did not result in a survival benefit for this subgroup. On the other hand, a worsening of low-grade TR was seen in more than 10% of the patients (n = 73/686), which was also associated with a worse prognosis. Predictors of worsening of TR after TAVR were adipositas, impaired right ventricular function and the presence of mild TR. Age, atrial fibrillation, COPD, impaired renal function and elevated cardiac biomarkers were risk factors for mortality after TAVR independent from the grade of TR. Conclusions. Not only pre-interventional, but also post-TAVR high-grade TR is associated with a worse prognosis after TAVR. TAVR can change concomitant tricuspid regurgitation, but improvement does not have any impact on short- and long-term survival. Worsening of TR after TAVR is possible and impairs the prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Producing and Testing Prototype Tissue-Engineered 3D Tri-Leaflet Valved Stents on Biodegradable Poly-ε-Caprolactone Scaffolds.
- Author
-
Lutter, Georg, Pommert, Nina Sophie, Zhang, Xiling, Seiler, Jette, Saeid Nia, Monireh, Meier, David, Sellers, Stephanie L., Gorb, Stanislav N., Hansen, Jan-Hinnerk, Seoudy, Hatim, Müller, Oliver J., Saad, Mohammed, Haneya, Assad, Frank, Derk, Puehler, Thomas, and Sathananthan, Janarthanan
- Subjects
PROSTHETIC heart valves ,PULMONARY valve ,MECHANICAL hearts ,HEART valves ,NANOFIBERS ,SCANNING electron microscopy ,FLUORESCENCE microscopy - Abstract
Transcatheter pulmonary valve replacement is a minimally-invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly evolving over the past years. Heart valve prostheses currently available still have major limitations. Therefore, one of the significant challenges for the future is the roll out of transcatheter tissue engineered pulmonary valve replacement to more patients. In the present study, biodegradable poly-ε-caprolactone (PCL) nanofiber scaffolds in the form of a 3D leaflet matrix were successfully seeded with human endothelial colony-forming cells (ECFCs), human induced pluripotent stem cell-derived MSCs (hMSCs), and porcine MSCs (pMSCs) for three weeks for the generation of 3D tissue-engineered tri-leaflet valved stent grafts. The cell adhesion, proliferation, and distribution of these 3D heart leaflets was analyzed using fluorescence microscopy and scanning electron microscopy (SEM). All cell lineages were able to increase the overgrown leaflet area within the three-week timeframe. While hMSCs showed a consistent growth rate over the course of three weeks, ECFSs showed almost no increase between days 7 and 14 until a growth spurt appeared between days 14 and 21. More than 90% of heart valve leaflets were covered with cells after the full three-week culturing cycle in nearly all leaflet areas, regardless of which cell type was used. This study shows that seeded biodegradable PCL nanofiber scaffolds incorporated in nitinol or biodegradable stents will offer a new therapeutic option in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. TAVR in TAVR: Where Are We in 2023 for Management of Failed TAVR Valves?
- Author
-
Meier, David, Tzimas, Georgios, Akodad, Mariama, Fournier, Stephane, Leipsic, Jonathon A., Blanke, Philipp, Wood, David A., Sellers, Stephanie L., Webb, John G., and Sathananthan, Janarthanan
- Abstract
Purpose of Review: As TAVR is increasingly performed on younger patients with a longer life expectancy, the number of redo-TAVR procedures is likely to increase in the coming years. Limited data is currently available on this sometimes challenging procedure. We provide a summary of currently published literature on management of patients with a failed transcatheter aortic valve. Recent Findings: Recent registry data have increased the clinical knowledge on redo-TAVR. Additionally, numerous bench studies have provided valuable insights into the technical aspects of redo-TAVR with various combinations of valve types. Summary: Redo-TAVR can be performed safely in selected cases with a high procedural success and good short-term outcomes. However, at present, the procedure remains relatively infrequent and many patients are not eligible. Bench testing can be useful to understand important concepts such as valve expansion, neoskirt, leaflet overhang, and leaflet deflection as well as their potential clinical implications. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Calcium Fracture and Device Over Expansion in Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valves.
- Author
-
Yeats, Breandan B., Sivakumar, Sri Krishna, Samaee, Milad, Polsani, Venkateshwar, Yadav, Pradeep K., Thourani, Vinod H., Sellers, Stephanie, Sathananthan, Janarthanan, and Dasi, Lakshmi P.
- Abstract
Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve disease (BAV) has potential risks of under expansion and non-circularity which may compromise long-term durability. This study aims to investigate calcium fracture and balloon over expansion in balloon-expandable TAVs on the stent deformation with the aid of simulation. BAV patients treated with the SAPIEN 3 Ultra with pre- and post-TAVR CTs were analyzed (n = 8). Simulations of the stent deployment were performed (1) with baseline simulation allowing calcium fracture, (2) without allowable calcium fracture and (3) with balloon over expansion (1 mm larger diameter). When compared to post CT, baseline simulations had minimal error in expansion (2.5% waist difference) and circularity (3.0% waist aspect ratio difference). When compared to baseline, calcium fracture had insignificant impact on the expansion (− 0.5% average waist difference) and circularity (− 1.6% average waist aspect ratio difference). Over expansion had significantly larger expansion compared to baseline (15.4% average waist difference) but had insignificant impact on the circularity (− 0.5% waist aspect ratio difference). We conclude that stent deformation can be predicted with minimal error, calcium fracture has small differences on the final stent deformation except in extreme calcified cases, and balloon over expansion expands the waist closer to nominal values. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Transcatheter Aortic Valve Implantation by Intercostal Access: Initial Experience with a No-Touch Technique.
- Author
-
Pommert, Nina Sophie, Zhang, Xiling, Puehler, Thomas, Seoudy, Hatim, Huenges, Katharina, Schoettler, Jan, Haneya, Assad, Friedrich, Christine, Sathananthan, Janarthanan, Sellers, Stephanie L., Meier, David, Mueller, Oliver J., Saad, Mohammed, Frank, Derk, and Lutter, Georg
- Subjects
HEART valve prosthesis implantation ,THORACOTOMY ,CORONARY artery bypass ,AORTIC stenosis ,AORTIC valve diseases ,PERIPHERAL vascular diseases ,PERCUTANEOUS coronary intervention - Abstract
Background: Transcatheter aortic valve implantation (TAVI) is now a well-established therapeutic option in an elderly high-risk patient cohort with aortic valve disease. Although most commonly performed via a transfemoral route, alternative approaches for TAVI are constantly being improved. Instead of the classical mini-sternotomy, it is possible to achieve a transaortic access via a right anterior mini-thoracotomy in the second intercostal space. We describe our experience with this sternum- and rib-sparing technique in comparison to the classical transaortic approach. Methods: Our retrospective study includes 173 patients who were treated in our institution between January 2017 and April 2020 with transaortic TAVI via either upper mini-sternotomy or intercostal thoracotomy. The primary endpoint was 30-day mortality, and secondary endpoints were defined as major postoperative complications that included admission to the intensive care unit and overall hospital stay, according to the Valve Academic Research Consortium 3. Results: Eighty-two patients were treated with TAo-TAVI by upper mini-sternotomy, while 91 patients received the intercostal approach. Both groups were comparable in age (mean age: 82 years) and in the proportion of female patients. The intercostal group had a higher rate of peripheral artery disease (41% vs. 22%, p = 0.008) and coronary artery disease (71% vs. 40%, p < 0.001) with a history of percutaneous coronary intervention or coronary artery bypass grafting, resulting in significantly higher preinterventional risk evaluation (EuroScore II 8% in the intercostal vs. 4% in the TAo group, p = 0.005). Successful device implantation and a reduction of the transvalvular gradient were achieved in all cases with a significantly lower rate of trace to mild paravalvular leakage in the intercostal group (12% vs. 33%, p < 0.001). The intercostal group required significantly fewer blood transfusions (0 vs. 2 units, p = 0.001) and tended to require less reoperation (7% vs. 15%, p = 0.084). Hospital stays (9 vs. 12 d, p = 0.011) were also shorter in the intercostal group. Short- and long-term survival in the follow-up showed comparable results between the two approaches (30-day, 6-month- and 2-year mortality: 7%, 23% and 36% in the intercostal vs. 9%, 26% and 33% in the TAo group) with acute kidney injury (AKI) and reintubation being independent risk factors for mortality. Conclusions: Transaortic TAVI via an intercostal access offers a safe and effective treatment of aortic valve stenosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Multi-species meta-analysis identifies transcriptional signatures associated with cardiac endothelial responses in the ischaemic heart.
- Author
-
Li, Ziwen, Solomonidis, Emmanouil G, Berkeley, Bronwyn, Tang, Michelle Nga Huen, Stewart, Katherine Ross, Perez-Vicencio, Daniel, McCracken, Ian R, Spiroski, Ana-Mishel, Gray, Gillian A, Barton, Anna K, Sellers, Stephanie L, Riley, Paul R, Baker, Andrew H, and Brittan, Mairi
- Subjects
VASCULAR endothelial cells ,ENDOTHELIAL cells ,HEART ,REGULATOR genes ,MYOCARDIAL infarction - Abstract
Aim Myocardial infarction remains the leading cause of heart failure. The adult human heart lacks the capacity to undergo endogenous regeneration. New blood vessel growth is integral to regenerative medicine necessitating a comprehensive understanding of the pathways that regulate vascular regeneration. We sought to define the transcriptomic dynamics of coronary endothelial cells following ischaemic injuries in the developing and adult mouse and human heart and to identify new mechanistic insights and targets for cardiovascular regeneration. Methods and results We carried out a comprehensive meta-analysis of integrated single-cell RNA-sequencing data of coronary vascular endothelial cells from the developing and adult mouse and human heart spanning healthy and acute and chronic ischaemic cardiac disease. We identified species-conserved gene regulatory pathways aligned to endogenous neovascularization. We annotated injury-associated temporal shifts of the endothelial transcriptome and validated four genes: VEGF-C, KLF4, EGR1, and ZFP36. Moreover, we showed that ZFP36 regulates human coronary endothelial cell proliferation and defined that VEGF-C administration in vivo enhances clonal expansion of the cardiac vasculature post-myocardial infarction. Finally, we constructed a coronary endothelial cell meta-atlas, CrescENDO, to empower future in-depth research to target pathways associated with coronary neovascularization. Conclusion We present a high-resolution single-cell meta-atlas of healthy and injured coronary endothelial cells in the mouse and human heart, revealing a suite of novel targets with great potential to promote vascular regeneration, and providing a rich resource for therapeutic development. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Redo Transcatheter Aortic Valve Implantation with the ALLEGRA Transcatheter Heart Valve: Insights from Bench Testing.
- Author
-
Akodad, Mariama, Kütting, Maximilian, Sellers, Stephanie, Kirsten, Alina, Marx, Philipp, Kim, Isabel, Cheung, Anson, Leipsic, Jonathon, Søndergaard, Lars, Toggweiler, Stefan, Wood, David A., Webb, John G., and Sathananthan, Janarthanan
- Abstract
Purpose: Failure of transcatheter heart valves (THV) may potentially be treated with repeat transcatheter aortic valve implantation (redo TAVI). We assessed hydrodynamic performance, stability and pinwheeling utilizing the ALLEGRA (New Valve Technology, Hechingen, Germany) THV, a CE approved and marketed THV in Europe, inside different THVs. Methods: Redo TAVI was simulated with the 27 mm ALLEGRA THV at three implantation depths (−4 mm, 0 mm and +4 mm) in seven different 'failed' THVs: 26 mm Evolut Pro, 25 mm Lotus, 25 mm JenaValve, 25 mm Portico, 23 mm Sapien 3, 27 mm ALLEGRA and M ACURATE neo. Hydrodynamic evaluation was performed according to International Standards Organization 5840-3:2021. Results: The ALLEGRA THV was stable with acceptable performance (gradient <20 mmHg, effective orifice area >2 cm
2 , and regurgitant fraction <20%) in all 'failed' THVs except the Evolut Pro at −4 mm implantation depth. In this configuration, the outflow of the ALLEGRA frame was constrained by the Evolut Pro THV and the ALLEGRA leaflets were unable to fully close. Pinwheeling was severe for the ALLEGRA in Evolut Pro. The neo-skirt was higher with taller frame THVs. Conclusion: The ALLEGRA THV had favorable hydrodynamic performance, stability and pinwheeling in all redo TAVI samples except the Evolut Pro at low implantation depth with compromised function. The choice of initial THV may have late implications on new THV choice and function. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Microcalcification and Thoracic Aortopathy: A Window Into Disease Severity.
- Author
-
Fletcher, Alexander J., Nash, Jennifer, Syed, Maaz B.J., Macaskill, Mark G., Tavares, Adriana A.S., Walker, Niki, Salcudean, Hannah, Leipsic, Jonathon A., Lim, Kelvin H.H., Madine, Jillian, Wallace, William, Field, Mark, Newby, David E., Bouchareb, Rihab, Seidman, Michael A., Akhtar, Riaz, and Sellers, Stephanie L.
- Published
- 2022
- Full Text
- View/download PDF
11. TAVR for All? The Surgical Perspective.
- Author
-
Zhang, Xiling, Puehler, Thomas, Frank, Derk, Sathananthan, Janarthanan, Sellers, Stephanie, Meier, David, Both, Marcus, Blanke, Philipp, Seoudy, Hatim, Saad, Mohammed, Müller, Oliver J., Sondergaard, Lars, and Lutter, Georg
- Published
- 2022
- Full Text
- View/download PDF
12. Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?
- Author
-
Xiling, Zhang, Puehler, Thomas, Sondergaard, Lars, Frank, Derk, Seoudy, Hatim, Mohammad, Baland, Müller, Oliver J., Sellers, Stephanie, Meier, David, Sathananthan, Janarthanan, and Lutter, Georg
- Subjects
MITRAL valve ,MITRAL valve insufficiency ,CLINICAL trials - Abstract
Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis.
- Author
-
Nørgaard, Bjarne L., Gaur, Sara, Fairbairn, Timothy A., Douglas, Pam S., Jensen, Jesper M., Patel, Manesh R., Ihdayhid, Abdul R., H Ko, Brian S., Sellers, Stephanie L., Weir-McCall, Jonathan, Matsuo, Hitoshi, Sand, Niels Peter R., Øvrehus, Kristian A., Rogers, Campbell, Mullen, Sarah, Nieman, Koen, Parner, Erik, Leipsic, Jonathon, and Abdulla, Jawdat
- Subjects
CHEST pain ,PROGNOSIS ,COMPUTED tomography ,MYOCARDIAL perfusion imaging - Published
- 2022
- Full Text
- View/download PDF
14. Effects of chronic kidney disease and declining renal function on coronary atherosclerotic plaque progression: a PARADIGM substudy.
- Author
-
Huang, Alex L., Leipsic, Jonathon A., Zekry, Sagit Ben, Sellers, Stephanie, Ahmadi, Amir A., Blanke, Philipp, Hadamitzky, Martin, Kim, Yong-Jin, Conte, Edoardo, Andreini, Daniele, Pontone, Gianluca, Budoff, Matthew J., Gottlieb, Ilan, Lee, Byoung Kwon, Chun, Eun Ju, Cademartiri, Filippo, Maffei, Erica, Marques, Hugo, Shin, Sanghoon, and Choi, Jung Hyun
- Subjects
CHRONIC kidney failure ,DISEASE progression ,GLOMERULAR filtration rate ,BLOOD vessels ,KIDNEY failure ,QUANTITATIVE research ,PARADIGMS (Social sciences) ,CORONARY artery disease ,DESCRIPTIVE statistics ,COMPUTED tomography - Abstract
Aims To investigate the change in atherosclerotic plaque volume in patients with chronic kidney disease (CKD) and declining renal function, using coronary computed tomography angiography (CCTA). Methods and results In total, 891 participants with analysable serial CCTA and available glomerular filtration rate (GFR, derived using Cockcroft–Gault formulae) at baseline (CCTA 1) and follow-up (CCTA 2) were included. CKD was defined as GFR <60 mL/min/1.73 m
2 . Declining renal function was defined as ≥10% drop in GFR from the baseline. Quantitative assessment of plaque volume and composition were performed on both scans. There were 203 participants with CKD and 688 without CKD. CKD was associated with higher baseline total plaque volume, but similar plaque progression, measured by crude (57.5 ± 3.4 vs. 65.9 ± 7.7 mm3 /year, P = 0.28) or annualized (17.3 ± 1.0 vs. 19.9 ± 2.0 mm3 /year, P = 0.25) change in total plaque volume. There were 709 participants with stable GFR and 182 with declining GFR. Declining renal function was independently associated with plaque progression, with higher crude (54.1 ± 3.2 vs. 80.2 ± 9.0 mm3 /year, P < 0.01) or annualized (16.4 ± 0.9 vs. 23.9 ± 2.6 mm3 /year, P < 0.01) increase in total plaque volume. In CKD, plaque progression was driven by calcified plaques whereas in patients with declining renal function, it was driven by non-calcified plaques. Conclusion Decline in renal function was associated with more rapid plaque progression, whereas the presence of CKD was not. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
15. Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions.
- Author
-
White, Zoe, Milad, Nadia, Sellers, Stephanie L., and Bernatchez, Pascal
- Subjects
ATHEROSCLEROSIS ,HDL cholesterol ,ATHEROSCLEROTIC plaque ,MEMBRANE proteins ,APOLIPOPROTEIN E ,HOMEOSTASIS - Abstract
Dysferlinopathies are a group of muscle disorders caused by mutations to dysferlin, a transmembrane protein involved in membrane patching events following physical damage to skeletal myofibers. We documented dysferlin expression in vascular tissues including non-muscle endothelial cells, suggesting that blood vessels may have an endogenous repair system that helps promote vascular homeostasis. To test this hypothesis, we generated dysferlin-null mice lacking apolipoprotein E (ApoE), a common model of atherosclerosis, dyslipidemia and endothelial injury when stressed with a high fat, and cholesterol-rich diet. Despite high dysferlin expression in mouse and human atheromatous plaques, loss of dysferlin did not affect atherosclerotic burden as measured in the aortic root, arch, thoracic, and abdominal aortic regions. Interestingly, we observed that dysferlin-null mice exhibit lower plasma high-density lipoprotein cholesterol (HDL-C) levels than their WT controls at all measured stages of the disease process. Western blotting revealed abundant dysferlin expression in protein extracts from mouse livers, the main regulator of plasma lipoprotein levels. Despite abnormal lipoprotein levels, Dysf/ApoE double knockout mice responded to cholesterol absorption blockade with lower total cholesterol and blunted atherosclerosis. Our study suggests that dysferlin does not protect against atherosclerosis or participate in cholesterol absorption blockade but regulates basal plasma lipoprotein composition. Dysferlinopathic patients may be dyslipidemic without greater atherosclerotic burden while remaining responsive to cholesterol absorption blockade. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework.
- Author
-
Khodaei, Seyedvahid, Henstock, Alison, Sadeghi, Reza, Sellers, Stephanie, Blanke, Philipp, Leipsic, Jonathon, Emadi, Ali, and Keshavarz-Motamed, Zahra
- Subjects
HEART valve prosthesis implantation ,AORTIC stenosis ,CARDIOVASCULAR diseases ,BLOOD flow ,HEART function tests - Abstract
One of the most common acute and chronic cardiovascular disease conditions is aortic stenosis, a disease in which the aortic valve is damaged and can no longer function properly. Moreover, aortic stenosis commonly exists in combination with other conditions causing so many patients suffer from the most general and fundamentally challenging condition: complex valvular, ventricular and vascular disease (C3VD). Transcatheter aortic valve replacement (TAVR) is a new less invasive intervention and is a growing alternative for patients with aortic stenosis. Although blood flow quantification is critical for accurate and early diagnosis of C3VD in both pre and post-TAVR, proper diagnostic methods are still lacking because the fluid-dynamics methods that can be used as engines of new diagnostic tools are not well developed yet. Despite remarkable advances in medical imaging, imaging on its own is not enough to quantify the blood flow effectively. Moreover, understanding of C3VD in both pre and post-TAVR and its progression has been hindered by the absence of a proper non-invasive tool for the assessment of the cardiovascular function. To enable the development of new non-invasive diagnostic methods, we developed an innovative image-based patient-specific computational fluid dynamics framework for patients with C3VD who undergo TAVR to quantify metrics of: (1) global circulatory function; (2) global cardiac function as well as (3) local cardiac fluid dynamics. This framework is based on an innovative non-invasive Doppler-based patient-specific lumped-parameter algorithm and a 3-D strongly-coupled fluid-solid interaction. We validated the framework against clinical cardiac catheterization and Doppler echocardiographic measurements and demonstrated its diagnostic utility by providing novel analyses and interpretations of clinical data in eleven C3VD patients in pre and post-TAVR status. Our findings position this framework as a promising new non-invasive diagnostic tool that can provide blood flow metrics while posing no risk to the patient. The diagnostic information, that the framework can provide, is vitally needed to improve clinical outcomes, to assess patient risk and to plan treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Ex vivo 18F-fluoride uptake and hydroxyapatite deposition in human coronary atherosclerosis.
- Author
-
Moss, Alastair J., Sim, Alisia M., Adamson, Philip D., Seidman, Michael A., Andrews, Jack P. M., Doris, Mhairi K., Shah, Anoop S. V., BouHaidar, Ralph, Alcaide-Corral, Carlos J., Williams, Michelle C., Leipsic, Jonathon A., Dweck, Marc R., MacRae, Vicky E., Newby, David E., Tavares, Adriana A. S., and Sellers, Stephanie L.
- Subjects
ACUTE coronary syndrome ,CALCIFICATIONS of the breast ,RADIOACTIVE tracers ,HYDROXYAPATITE ,OSTEOPONTIN - Abstract
Early microcalcification is a feature of coronary plaques with an increased propensity to rupture and to cause acute coronary syndromes. In this ex vivo imaging study of coronary artery specimens, the non-invasive imaging radiotracer,
18 F-fluoride, was highly selective for hydroxyapatite deposition in atherosclerotic coronary plaque. Specifically, coronary18 F-fluoride uptake had a high signal to noise ratio compared with surrounding myocardium that makes it feasible to identify coronary mineralisation activity. Areas of18 F-fluoride uptake are associated with osteopontin, an inflammation-associated glycophosphoprotein that mediates tissue mineralisation, and Runt-related transcription factor 2, a nuclear protein involved in osteoblastic differentiation. These results suggest that18 F-fluoride is a non-invasive imaging biomarker of active coronary atherosclerotic mineralisation. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
18. Performance of the TRUE dilatation balloon valvuloplasty catheter beyond rated burst pressure: A bench study.
- Author
-
Sathananthan, Janarthanan, Hensey, Mark, Sellers, Stephanie, Barlow, Aaron M., Chhatriwalla, Adnan K., Allen, Keith B., Cheung, Anson, Søndergaard, Lars, Blanke, Philipp, Ye, Jian, Leipsic, Jonathan, Wood, David, and Webb, John
- Published
- 2020
- Full Text
- View/download PDF
19. Impact of sublingual nitroglycerin dosage on FFRCT assessment and coronary luminal volume-to-myocardial mass ratio.
- Author
-
Holmes, Kenneth R., Fonte, Tim A., Weir-McCall, Jonathan, Anastasius, Malcolm, Blanke, Philipp, Payne, Geoffrey W., Ellis, Jen, Murphy, Darra T., Taylor, Charles, Leipsic, Jonathon A., and Sellers, Stephanie L.
- Subjects
NITROGLYCERIN ,WILCOXON signed-rank test ,HYPEREMIA ,DRUG dosage ,CORONARY vasospasm ,COMPUTED tomography ,CORONARY arteries - Abstract
Objectives: Fractional flow reserve computed tomography (FFRCT) depends upon nitroglycerin (NTG) inducing maximal hyperemia. However, the impact of NTG dosages on FFRCT analysis including coronary volume-to-mass ratio (V/M) is unknown.Methods: Eighty patients with repeat coronary CT angiograms (CCTAs) with different sublingual spray NTG doses (0.4 mg and 0.8 mg) were retrospectively analyzed with 45 patients excluded. Patient and scan demographics, post-stenosis and nadir FFRCT values, coronary volume, and coronary volume-to-mass ratio (V/M) were compared at initial CCTA (0.4 mg NTG) and follow-up CCTA (0.8 mg NTG). Differences were compared by Wilcoxon signed-rank test.Results: Thirty-five patients were included (time between CCTAs, 3.9 ± 1.6 years). Segment involvement score was 2.4 ± 3.3 and 2.8 ± 3.4 at initial and repeat CCTA (0.4 and 0.8 mg NTG), respectively (p = 0.004). There was similar image quality (4.1 ± 0.7 vs 4.1 ± 0.8; p = 0.51). Nadir FFRCT values did not differ in the left (0.4 mg, 0.80 ± 0.08 vs 0.8 mg, 0.80 ± 0.03; p = 0.66), right (0.4 mg, 0.90 ± 0.04 vs 0.8 mg, 0.90 ± 0.06; p = 0.25), or circumflex coronaries (0.4 mg, 0.87 ± 0.06 vs 0.8 mg, 0.88 ± 0.06; p = 0.34). Post-stenosis FFRCT values did not differ (p = 0.65). Coronary volume increased with 0.8 mg of NTG (2639 ± 753 mm3 vs 2844.8 ± 827 mm3; p = 0.009) but V/M ratio did not (p = 0.20).Conclusions: Use of 0.8 mg versus 0.4 mg of NTG in routine clinical CCTAs significantly increased coronary volume determined from FFRCT analysis but did not alter FFRCT or V/M. Further evaluation of repeat CCTAs in a more contemporaneous fashion using varied nitrate doses and disease severity is needed.Key Points: • Fractional flow reserve from computed tomography (FFRCT) is a noninvasive method for evaluating the coronary arteries and relies on nitroglycerin (NTG) to induce coronary vasodilation, but the impact of different NTG dosages is unknown. • Retrospective analysis evaluated use of different NTG doses on FFRCT. • Increased NTG dose increased coronary luminal volume on FFRCTanalysis, but did not change FFRCTvalues. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
20. Mesohabitat current velocity effects on Didymosphenia geminata and macroinvertebrates in a SE USA hypolimnetic tailwater.
- Author
-
Green, Matthew W., Blum IV, Peter W., Sellers, Stephanie C., Gangloff, Michael M., Jacobus, Luke M., and Tuberty, Shea R.
- Abstract
The diatom Didymosphenia geminata is known to alter benthic habitat and macroinvertebrate diversity and community structure. Associations between macroinvertebrate communities and D. geminata biomass in riffle and run mesohabitats were investigated in the South Fork Holston River in Tennessee and Virginia, USA. We found that low current velocity, low turbidity, and high dissolved oxygen (DO) were strong predictors of D. geminata mat presence. Didymosphenia geminata ash-free dry mass was significantly higher in run mesohabitats with low current velocity (CV) than in riffle mesohabitats with higher CV. Macroinvertebrate alpha diversity (Shannon Diversity H') was only marginally significantly different between riffle and runs, while beta diversity (community composition) was highly significantly different between these mesohabitats. NMDS analyses found that D. geminata was a relatively unimportant predictor of changes in community structure relative to specific conductance, CV, DO, and turbidity. However, effects of D. geminata on macroinvertebrates appear to be very taxon specific with effects on individual taxa potentially masked by tailwater effects on general macroinvertebrate diversity in global analyses. We observed that taxon-specific effects include, but are not limited to, (1) reduction of bryophyte microhabitat utilized by dominant ephemeropterans, trichopterans, amphipods, coleopterans, and some chironomid genera in run mesohabitats from competition with D. geminata for substrate attachment space; and (2) differences in utilization of D. geminata mat biomass as a food resource and microhabitat for chironomids. Our insights into taxon-specific effects of D. geminata on macroinvertebrates open up multiple avenues for experimentation in which to validate our observational findings. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. Overexpansion of older generation balloon expandable transcatheter heart valves: An ex‐vivo bench study.
- Author
-
Sathananthan, Janarthanan, Sellers, Stephanie, Barlow, Aaron, Hensey, Mark, Landes, Uri, Cheung, Anson, Ye, Jian, Alkhodair, Abdullah, Blanke, Philipp, Søndergaard, Lars, Pibarot, Phillippe, Wood, David, Leipsic, Jonathan, and Webb, John
- Published
- 2019
- Full Text
- View/download PDF
22. Anatomic Considerations for Injection of the Lateral Atlanto-Axial Joint.
- Author
-
McNabney, Charis, Chavda, Anesh, Alabsi, Hatim, Sellers, Stephanie L, Murphy, Darra T, and Fenton, David
- Subjects
BLOOD vessels ,COMPUTED tomography ,DIAGNOSTIC imaging ,INTRA-articular injections ,MENINGES ,PATIENT safety ,VERTEBRAL artery ,PAIN management ,ATLANTO-axial joint ,RETROSPECTIVE studies ,DESCRIPTIVE statistics - Abstract
Objective We aimed to define the potential complications of intra-articular steroid injections into the lateral C1-2 articulations and safety margins to the relevant structures. Methods A total of 488 contrast-enhanced computed tomography angiogram (CTA) "arch to vertex" studies were retrospectively reviewed for theoretical intersection of the vertebral artery or thecal sac and distance of the named structures from the anticipated/theoretical trajectory of injection into the lateral C1-C2 joint. Results Patients were 60.4±15.8 years old and 55.5% male. In total, seven vertebral arteries and 11 thecal sac theoretical intersections were found. In cases without a direct intersection, the distance from the trajectory (range) was 0.71±0.18 (0.22–1.44) cm to the vertebral artery and 0.6±0.22 (0.14–1.8) cm to the thecal sac. Conclusions Although injection of steroid into the lateral C1-C2 articulation for pain management has historically been reported to carry risk of severe complications due to close proximity and location variability of surrounding structures, our study quantifies the potential risk of such injections. Further, our analysis suggests that preprocedural imaging should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Inonotus obliquus attenuates histamine-induced microvascular inflammation.
- Author
-
Javed, Sumreen, Mitchell, Kevin, Sidsworth, Danielle, Sellers, Stephanie L., Reutens-Hernandez, Jennifer, Massicotte, Hugues B., Egger, Keith N., Lee, Chow H., and Payne, Geoffrey W.
- Subjects
ENDOTHELIUM ,MAST cells ,ANTIHISTAMINES ,CONNECTIVE tissue cells ,VASCULAR endothelium ,GLUTEAL muscles - Abstract
Cell-to-cell communication is a key element of microvascular blood flow control, including rapidly carrying signals through the vascular endothelium in response to local stimuli. This cell-to-cell communication is negatively impacted during inflammation through the disruption of junctional integrity. Such disruption is associated with promoting the onset of cardiovascular diseases as a result of altered microvascular blood flow regulation. Therefore, understanding the mechanisms how inflammation drives microvascular dysfunction and compounds that mitigate such inflammation and dysfunction are of great interest for development. As such we aimed to investigate extracts of mushrooms as potential novel compounds. Using intravital microscopy, the medicinal mushroom, Inonotus obliquus was observed, to attenuate histamine-induced inflammation conducted vasodilation in second-order arterioles in the gluteus maximus muscle of C57BL/6 mice. Mast cell activation by C48/80 similarly disrupted endothelial junctions and conducted vasodilation but only histamine was blocked by the histamine antagonist, pyrilamine not C48/80 suggesting the importance of mast cell activation. Data presented here supports that histamine induced inflammation is a major disruptor of junctional integrity, and highlights the important anti-inflammatory properties of Inonotus obliquus focusing future assessment of mast cells as putative target for Inonotus obliquus. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B.
- Author
-
White, Zoe, Milad, Nadia, Tehrani, Arash Y., Chen, William Wei-Han, Donen, Graham, Sellers, Stephanie L., and Bernatchez, Pascal
- Subjects
ANGIOTENSIN II ,LIMB-girdle muscular dystrophy ,ANGIOTENSIN receptors ,QUADRICEPS muscle ,MUSCLES ,DEVELOPMENTAL biology ,OCULAR hypotony ,TRICEPS - Abstract
There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth factor-β (TGF-β) properties, can protect muscles in various types of MD such as Duchenne MD, suggesting a potential benefit for LGMD2B patients. Herein, we show in a mild, dysferlin-null mouse model of LGMD2B that losartan increased quadriceps muscle fibrosis (142%; P<0.0001). In a severe, atherogenic diet-fed model of LGMD2B recently described by our group, losartan further exacerbated dysferlin-null mouse muscle wasting in quadriceps and triceps brachii, two muscles typically affected by LGMD2B, by 40% and 51%, respectively (P<0.05). Lower TGF-β signalling was not observed with losartan, therefore plasma levels of atherogenic lipids known to aggravate LGMD2B severity were investigated. We report that losartan increased both plasma triglycerides and cholesterol concentrations in dysferlin-null mice. Other protective properties of losartan, such as increased nitric oxide release and BP lowering, were also reduced in the absence of dysferlin expression. Our data suggest that LGMD2B patients may show some resistance to the primary BP-lowering effects of losartan along with accelerated muscle wasting and dyslipidemia. Hence, we urge caution on the use of ARBs in this population as their ATR1 pathway may be dysfunctional. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Molecular Coronary Plaque Imaging Using 18F-Fluoride.
- Author
-
Moss, Alastair J., Doris, Mhairi K., Andrews, Jack P. M., Bing, Rong, Daghem, Marwa, van Beek, Edwin J. R., Forsyth, Laura, Shah, Anoop S. V., Williams, Michelle C., Sellers, Stephanie, Leipsic, Jonathon, Dweck, Marc R., Parker, Richard A., Newby, David E., and Adamson, Philip D.
- Published
- 2019
- Full Text
- View/download PDF
26. Novel method for assessing myocardium at risk: a new arrow in the diagnostic quiver of coronary CT.
- Author
-
Ihdayhid, Abdul Rahman and Sellers, Stephanie L.
- Subjects
CORONARY disease ,CORONARY artery stenosis ,CORONARY circulation ,ACUTE coronary syndrome ,COMPUTATIONAL fluid dynamics ,ATHEROSCLEROTIC plaque ,MYOCARDIUM ,COMPUTED tomography ,PERFUSION - Published
- 2020
- Full Text
- View/download PDF
27. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
- Author
-
Milad, Nadia, White, Zoe, Tehrani, Arash Y., Sellers, Stephanie, Rossi, Fabio M. V., and Bernatchez, Pascal
- Subjects
BLOOD lipids ,DUCHENNE muscular dystrophy ,DYSTROPHIN ,CREATINE kinase ,HIGH density lipoproteins - Abstract
Background: Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin expression and leads to severe ambulatory and cardiac function decline. However, the dystrophin-deficient mdx murine model of DMD only develops a very mild form of the disease. Our group and others have shown vascular abnormalities in animal models of MD, a likely consequence of the fact that blood vessels express the same dystrophin-associated glycoprotein complex (DGC) proteins as skeletal muscles. Methods: To test the blood vessel contribution to muscle damage in DMD, mdx4cv mice were given elevated lipid levels via apolipoprotein E (ApoE) gene knockout combined with normal chow or lipid-rich Western diets. Ambulatory function and heart function (via echocardiogram) were assessed at 4 and 7 months of age. After sacrifice, muscle histology and aortic staining were used to assess muscle pathology and atherosclerosis development, respectively. Plasma levels of total cholesterol, high-density lipoprotein (HDL), triglycerides, and creatine kinase (CK) were also measured. Results: Although there was an increase in left ventricular heart volume in mdx-ApoE mice compared to that in mdx mice, parameters of heart function were not affected. Compared with wild-type and ApoE-null, only mdx-ApoE KO mice showed significant ambulatory dysfunction. Despite no significant difference in plasma CK, histological analyses revealed that elevated plasma lipids in chow- and Western diet-fed mdx-ApoE mice was associated with severe exacerbation of muscle pathology compared to mdx mice: significant increase in myofiber damage and fibrofatty replacement in the gastrocnemius and triceps brachii muscles, more reminiscent of human DMD pathology. Finally, although both ApoE and mdx-ApoE groups displayed increased plasma lipids, mdx-ApoE exhibited atherosclerotic plaque deposition equal to or less than that of ApoE mice. Conclusions: Since others have shown that lipid abnormalities correlate with DMD severity, our data suggest that plasma lipids could be primary contributors to human DMD severity and that the notoriously mild phenotype of mdx mice might be attributable in part to their endogenously low plasma lipid profiles. Hence, DMD patients may benefit from lipid-lowering and vascular-targeted therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
28. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis.
- Author
-
Williams, Michelle Claire, Newby, David E., Nørgaard, Bjarne L, Gaur, Sara, Fairbairn, Timothy A, Douglas, Pam S, Jensen, Jesper M, Patel, Manesh R, Ihdayhid, Abdul R, Ko, Brian S H, Sellers, Stephanie L, Weir-McCall, Jonathan, Matsuo, Hitoshi, Sand, Niels Peter R, Øvrehus, Kristian A, Rogers, Campbell, Mullen, Sarah, Nieman, Koen, Parner, Erik, and Leipsic, Jonathon
- Subjects
PROGNOSIS ,COMPUTED tomography ,CHEST pain ,MYOCARDIAL infarction - Abstract
Objectives: To obtain more powerful assessment of the prognostic value of fractional flow reserveCT testing we performed a systematic literature review and collaborative meta-analysis of studies that assessed clinical outcomes of CT-derived calculation of FFR (FFRCT) (HeartFlow) analysis in patients with stable coronary artery disease (CAD).Methods: We searched PubMed and Web of Science electronic databases for published studies that evaluated clinical outcomes following fractional flow reserveCT testing between 1 January 2010 and 31 December 2020. The primary endpoint was defined as 'all-cause mortality (ACM) or myocardial infarction (MI)' at 12-month follow-up. Exploratory analyses were performed using major adverse cardiovascular events (MACEs, ACM+MI+unplanned revascularisation), ACM, MI, spontaneous MI or unplanned (>3 months) revascularisation as the endpoint.Results: Five studies were identified including a total of 5460 patients eligible for meta-analyses. The primary endpoint occurred in 60 (1.1%) patients, 0.6% (13/2126) with FFRCT>0.80% and 1.4% (47/3334) with FFRCT ≤0.80 (relative risk (RR) 2.31 (95% CI 1.29 to 4.13), p=0.005). Likewise, MACE, MI, spontaneous MI or unplanned revascularisation occurred more frequently in patients with FFRCT ≤0.80 versus patients with FFRCT >0.80. Each 0.10-unit FFRCT reduction was associated with a greater risk of the primary endpoint (RR 1.67 (95% CI 1.47 to 1.87), p<0.001).Conclusions: The 12-month outcomes in patients with stable CAD show low rates of events in those with a negative FFRCT result, and lower risk of an unfavourable outcome in patients with a negative test result compared with patients with a positive test result. Moreover, the FFRCT numerical value was inversely associated with outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
29. Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis.
- Author
-
Sharma, Arpeeta, Sellers, Stephanie, Stefanovic, Nada, Leung, Cleo, Sih Min Tan, Huet, Olivier, Granville, David J., Cooper, Mark E., de Haan, Judy B., Bernatchez, Pascal, and Tan, Sih Min
- Subjects
ENDOTHELIUM diseases ,NITRIC-oxide synthases ,ATHEROSCLEROSIS ,DIABETES ,CAVEOLINS ,OXIDATIVE stress ,PEPTIDES ,LEUCOCYTES ,ANIMAL experimentation ,CARRIER proteins ,CELLULAR signal transduction ,DIABETIC angiopathies ,ENDOTHELIUM ,EPITHELIAL cells ,MICE ,OXIDOREDUCTASES ,RESEARCH funding - Abstract
Patients with diabetes have an increased risk of developing atherosclerosis. Endothelial dysfunction, characterized by the lowered bioavailability of endothelial NO synthase (eNOS)-derived NO, is a critical inducer of atherosclerosis. However, the protective aspect of eNOS in diabetes-associated atherosclerosis remains controversial, a likely consequence of its capacity to release both protective NO or deleterious oxygen radicals in normal and disease settings, respectively. Harnessing the atheroprotective activity of eNOS in diabetic settings remains elusive, in part due to the lack of endogenous eNOS-specific NO release activators. We have recently shown in vitro that eNOS-derived NO release can be increased by blocking its binding to Caveolin-1, the main coat protein of caveolae, using a highly specific peptide, CavNOxin. However, whether targeting eNOS using this peptide can attenuate diabetes-associated atherosclerosis is unknown. In this study, we show that CavNOxin can attenuate atherosclerotic burden by ∼84% in vivo. In contrast, mice lacking eNOS show resistance to CavNOxin treatment, indicating eNOS specificity. Mechanistically, CavNOxin lowered oxidative stress markers, inhibited the expression of proatherogenic mediators, and blocked leukocyte-endothelial interactions. These data are the first to show that endogenous eNOS activation can provide atheroprotection in diabetes and suggest that CavNOxin is a viable strategy for the development of antiatherosclerotic compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. Regulated Apoptosis of Genetically Modified Hematopoietic Stem and Progenitor Cells Via an Inducible Caspase-9 Suicide Gene in Rhesus Macaques.
- Author
-
Barese, Cecilia N., Felizardo, Tania C., Sellers, Stephanie E., Keyvanfar, Keyvan, Di Stasi, Antonio, Metzger, Mark E., Krouse, Allen E., Donahue, Robert E., Spencer, David M., and Dunbar, Cynthia E.
- Subjects
APOPTOSIS ,HEMATOPOIETIC stem cells ,CARCINOGENESIS ,PROGENITOR cells ,CASPASES ,RHESUS monkeys - Abstract
A bstract The high risk of insertional oncogenesis reported in clinical trials using integrating retroviral vectors to genetically modify hematopoietic stem and progenitor cells (HSPCs) requires the development of safety strategies to minimize risks associated with novel cell and gene therapies. The ability to ablate genetically modified cells in vivo is desirable, should an abnormal clone emerge. Inclusion of 'suicide genes' in vectors to facilitate targeted ablation of vector-containing abnormal clones in vivo is one potential safety approach. We tested whether the inclusion of the 'inducible Caspase-9' (iCasp9) suicide gene in a gamma-retroviral vector facilitated efficient elimination of vector-containing HSPCs and their hematopoietic progeny in vivo long-term, in an autologous non-human primate transplantation model. Following stable engraftment of iCasp9 expressing hematopoietic cells in rhesus macaques, administration of AP1903, a chemical inducer of dimerization able to activate iCasp9, specifically eliminated vector-containing cells in all hematopoietic lineages long-term, suggesting activity at the HSPC level. Between 75% and 94% of vector-containing cells were eliminated by well-tolerated AP1903 dosing, but lack of complete ablation was linked to lower iCasp9 expression in residual cells. Further investigation of resistance mechanisms demonstrated upregulation of Bcl-2 in hematopoietic cell lines transduced with the vector and resistant to AP1903 ablation. These results demonstrate both the potential and the limitations of safety approaches using iCasp9 to HSPC-targeted gene therapy settings, in a model with great relevance to clinical development. S tem C ells 2015;33:91-100 [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
31. Developing a Deeper Understanding of Sex Differences in the Diagnostic Performance of Computed Tomographic Perfusion Imaging Toward a More Personalized Approach.
- Author
-
Shaw Hua (Anthony) Kueh, Sellers, Stephanie, and Leipsic, Jonathon
- Published
- 2016
- Full Text
- View/download PDF
32. Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect.
- Author
-
Zhang, Xiling, Puehler, Thomas, Seiler, Jette, Gorb, Stanislav N., Sathananthan, Janarthanan, Sellers, Stephanie, Haneya, Assad, Hansen, Jan-Hinnerk, Uebing, Anselm, Müller, Oliver J., Frank, Derk, and Lutter, Georg
- Subjects
PULMONARY valve ,TISSUE engineering ,CONGENITAL heart disease ,SURGICAL stents ,HEART assist devices ,HEART valves - Abstract
Patients with the complex congenital heart disease (CHD) are usually associated with right ventricular outflow tract dysfunction and typically require multiple surgical interventions during their lives to relieve the right ventricular outflow tract abnormality. Transcatheter pulmonary valve replacement was used as a non-surgical, less invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly developing over the past years. Despite the current favorable results of transcatheter pulmonary valve replacement, many patients eligible for pulmonary valve replacement are still not candidates for transcatheter pulmonary valve replacement. Therefore, one of the significant future challenges is to expand transcatheter pulmonary valve replacement to a broader patient population. This review describes the limitations and problems of existing techniques and focuses on decellularized tissue engineering for pulmonary valve stenting. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Biodegradable Poly-ε-Caprolactone Scaffolds with ECFCs and iMSCs for Tissue-Engineered Heart Valves.
- Author
-
Lutter, Georg, Puehler, Thomas, Cyganek, Lukas, Seiler, Jette, Rogler, Anita, Herberth, Tanja, Knueppel, Philipp, Gorb, Stanislav N., Sathananthan, Janarthanan, Sellers, Stephanie, Müller, Oliver J., Frank, Derk, and Haben, Irma
- Subjects
PROSTHETIC heart valves ,HEART valves ,PULMONARY valve ,PLURIPOTENT stem cells ,YOUNG'S modulus ,COLONIZATION (Ecology) ,SCANNING electron microscopy - Abstract
Clinically used heart valve prostheses, despite their progress, are still associated with limitations. Biodegradable poly-ε-caprolactone (PCL) nanofiber scaffolds, as a matrix, were seeded with human endothelial colony-forming cells (ECFCs) and human induced-pluripotent stem cells-derived MSCs (iMSCs) for the generation of tissue-engineered heart valves. Cell adhesion, proliferation, and distribution, as well as the effects of coating PCL nanofibers, were analyzed by fluorescence microscopy and SEM. Mechanical properties of seeded PCL scaffolds were investigated under uniaxial loading. iPSCs were used to differentiate into iMSCs via mesoderm. The obtained iMSCs exhibited a comparable phenotype and surface marker expression to adult human MSCs and were capable of multilineage differentiation. EFCFs and MSCs showed good adhesion and distribution on PCL fibers, forming a closed cell cover. Coating of the fibers resulted in an increased cell number only at an early time point; from day 7 of colonization, there was no difference between cell numbers on coated and uncoated PCL fibers. The mechanical properties of PCL scaffolds under uniaxial loading were compared with native porcine pulmonary valve leaflets. The Young's modulus and mean elongation at F
max of unseeded PCL scaffolds were comparable to those of native leaflets (p = ns.). Colonization of PCL scaffolds with human ECFCs or iMSCs did not alter these properties (p = ns.). However, the native heart valves exhibited a maximum tensile stress at a force of 1.2 ± 0.5 N, whereas it was lower in the unseeded PCL scaffolds (0.6 ± 0.0 N, p < 0.05). A closed cell layer on PCL tissues did not change the values of Fmax (ECFCs: 0.6 ± 0.1 N; iMSCs: 0.7 ± 0.1 N). Here, a successful two-phase protocol, based on the timed use of differentiation factors for efficient differentiation of human iPSCs into iMSCs, was developed. Furthermore, we demonstrated the successful colonization of a biodegradable PCL nanofiber matrix with human ECFCs and iMSCs suitable for the generation of tissue-engineered heart valves. A closed cell cover was already evident after 14 days for ECFCs and 21 days for MSCs. The PCL tissue did not show major mechanical differences compared to native heart valves, which was not altered by short-term surface colonization with human cells in the absence of an extracellular matrix. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
34. Nitric Oxide and TNFα Are Critical Regulators of Reversible Lymph Node Vascular Remodeling and Adaptive Immune Response.
- Author
-
Sellers, Stephanie L., Iwasaki, Akiko, and Payne, Geoffrey W.
- Subjects
TUMOR necrosis factor receptors ,NITRIC oxide ,LYMPH node physiology ,IMMUNE response ,MOLECULAR biology ,HERPES simplex ,CELLULAR signal transduction ,SEXUALLY transmitted diseases - Abstract
Lymph node (LN) vascular growth, at the level of the main arteriole, was recently characterized for the first time during infection. Arteriole diameter was shown to increase for at least seven days and to occur via a CD4
+ T cell dependent mechanism, with vascular expansion playing a critical role in regulating induction of adaptive immune response. Here, using intravital microscopy of the inguinal LN during herpes simplex type II (HSV-2) infection, the data provides the first studies that demonstrate arteriole expansion during infection is a reversible vascular event that occurs via eutrophic outward remodeling. Furthermore, using genetic ablation models, and pharmacological blockade, we reveal arteriole remodeling and LN hypertrophy to be dependent upon both endothelial nitric oxide synthase (eNOS) and TNFα expression. Additionally, we reveal transient changes in nitric oxide (NO) levels to be a notable feature of response to viral infection and LN vascular remodeling and provide evidence that mast cells are the critical source of TNFα required to drive arteriole remodeling. Overall, this study is the first to fully characterize LN arteriole vascular changes throughout the course of infection. It effectively reveals a novel role for NO and TNFα in LN cellularity and changes in LN vascularity, which represent key advances in understanding LN vascular physiology and adaptive immune response. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
35. Caveolin as a potential drug target for cardiovascular protection.
- Author
-
Sellers, Stephanie L., Trane, Andy E., and Bernatchez, Pascal N.
- Subjects
CAVEOLAE ,CAVEOLINS ,DRUG target ,CARDIOVASCULAR disease treatment ,CARDIOVASCULAR agents - Abstract
Caveolae and caveolin are key players in a number of disease processes. Current research indicates that caveolins play a significant role in cardiovascular disease and dysfunction. The far-reaching roles of caveolins in disease and dysfunction make them particularly notable therapeutic targets. In particular, caveolin-1 (Cav-1) and caveolin-3 (Cav-3) have been identified as potential regulators of vascular dysfunction and heart disease and might even confer cardiac protection in certain settings. Such a central role in vascular health therefore makes manipulation of Cav-1/3 function or expression levels clear therapeutic targets in a variety of cardiovascular related disease states. Here, we highlight the role of Cav-1 and Cav-3 in cardiovascular health and explore the potential of Cav-1 and Cav-3 derived experimental therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
36. Caveolin as a Potential Drug Target For Cardiovascular Protection.
- Author
-
Sellers, Stephanie L., Trane, Andy E., and Bernatchez, Pascal N.
- Subjects
CAVEOLINS ,DRUG target ,CARDIOVASCULAR agents ,CAVEOLAE ,CARDIOVASCULAR disease treatment - Abstract
Caveolae and caveolin are key players in a number of disease processes. Current research indicates that caveolins play a significant role in cardiovascular disease and dysfunction. The far-reaching roles of caveolins in disease and dysfunction make them particularly notable therapeutic targets. In particular, caveolin-1 and caveolin-3 have been identified as potential regulators of vascular dysfunction and heart disease, and might even confer cardiac protection in certain settings. Such a central role in vascular health therefore makes manipulation of caveolin-1/3 function or expression levels clear therapeutic targets in a variety of cardiovascular related disease states. Here, we highlight the role of caveolin-1 and -3 in cardiovascular health and explore the potential of caveolin-1 and caveolin-3 derived experimental therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
37. CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input.
- Author
-
Kumamoto, Yosuke, Mattei, Lisa M., Sellers, Stephanie, Payne, Geoffrey W., and Iwasaki, Akiko
- Subjects
LYMPHOCYTES ,DENDRITIC cells ,IMMUNOLOGY ,LYMPHOID tissue ,IMMUNE response - Abstract
Rapid induction of CD8
+ cytotoxic T lymphocyte (CTL) responses is critical to combat acute infection with intracellular pathogens. CD4+ T cells help prime antigen-specific CTLs in secondary lymphoid organs after infection in the periphery. Although the frequency of naïve precursors is very low, the immune system is able to efficiently screen for cognate CTLs through mechanisms that are not well understood. Here we examine the role of CD4+ T cells in early phases of the immune response. We show that CD4+ T cells help optimal CTL expansion by facilitating entry of naïve polyclonal CD8+ T cells into the draining lymph node (dLN) early after infection or immunization. CD4+ T cells also facilitate input of naïve B cells into reactive LNs. Such "help" involves expansion of the arteriole feeding the dLN and enlargement of the dLN through activation of dendritic cells. In an antigen and CD40-dependent manner, CD4+ T cells activate dendritic cells to support naïve lymphocyte recruitment to the dLN. Our results reveal a previously unappreciated mode of CD4+ T-cell help, whereby they increase the input of naïve lymphocytes to the relevant LN for efficient screening of cognate CD8+ T cells. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
38. No Evidence of Clonal Dominance in Primates up to 4 Years Following Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long-Term Repopulating Cells.
- Author
-
Bozorgmehr, Farastuk, Laufs, Stefanie, Sellers, Stephanie E., Roeder, Ingo, Werner J.Zeller, Dunbar, Cynthia E., and Fruehauf, Stefan
- Subjects
MULTIDRUG resistance ,HEMATOLOGICAL manifestations of general diseases ,TUMOR treatment ,HEMATOPOIETIC stem cells ,DRUG lipophilicity ,HUMAN biology ,RHESUS monkeys - Abstract
Previous murine studies have suggested that retroviral multidrug resistance 1 (MDR1) gene transfer may be associated with a myeloproliferative disorder. Analyses at a clonal level and prolonged long-term follow-up in a model with more direct relevance to human biology were lacking. In this study, we analyzed the contribution of individual CD34-selected peripheral blood progenitor cells to long-term rhesus macaque hematopoiesis after transduction with a retroviral vector either expressing the multidrug resistance 1 gene (HaMDR1 vector) or expressing the neomycin resistance (NeoR) gene (G1Na vector). We found a total of 122 contributing clones from 8 weeks up to 4 years after transplantation. One hundred two clones contained the G1Na vector, whereas only 20 clones contained the HaMDR1 vector. Here, we show for the first time realtime polymerase chain reaction based quantification of individual transduced cell clones constituting 0.0008% ± 0.0003% to 0.0041% ± 0.00032% of primate peripheral blood cells. No clonal dominance was observed. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
39. Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells.
- Author
-
Hematti, Peiman, Bum-kee Hong, Ferguson, Cole, Adler, Rima, Hanawa, Hideki, Sellers, Stephanie, Holt, Ingeborg E., Eckfeldt, Craig E., Sharma, Yugal, Schmidt, Manfred, von Kalle, Christof, Persons, Derek A., Billings, Eric M., Verfaillie, Catherine M., Nienhuis, Arthur W., Wolfsberg, Tyra G., Dunbar, Cynthia E., and Calmels, Boris
- Subjects
GENOMES ,STEM cells ,MOUSE leukemia viruses ,SIMIAN viruses ,HEMATOPOIETIC stem cells ,GENETIC transformation - Abstract
Murine leukemia virus (MLV)-derived vectors are widely used for hematopoietic stem cell (HSC) gene transfer, but lentiviral vectors such as the simian immunodeficiency virus (SIV) may allow higher efficiency transfer and better expression. Recent studies in cell lines have challenged the notion that retroviruses and retroviral vectors integrate randomly into their host genome. Medical applications using these vectors are aimed at HSCs, and thus large-scale comprehensive analysis of MLV and SIV integration in long-term repopulating HSCs is crucial to help develop improved integrating vectors. We studied integration sites in HSCs of rhesus monkeys that had been transplanted 6 mo to 6 y prior with MLV- or SIV-transduced CD34
+ cells. Unique MLV (491) and SIV (501) insertions were compared to a set of in silico-generated random integration sites. While MLV integrants were located predominantly around transcription start sites, SIV integrants strongly favored transcription units and gene-dense regions of the genome. These integration patterns suggest different mechanisms for integration as well as distinct safety implications for MLV versus SIV vectors. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
40. Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells.
- Author
-
Hematti, Peiman, Hong, Bum-Kee, Ferguson, Cole, Adler, Rima, Hanawa, Hideki, Sellers, Stephanie, Holt, Ingeborg E, Eckfeldt, Craig E, Sharma, Yugal, Schmidt, Manfred, von Kalle, Christof, Persons, Derek A, Billings, Eric M, Verfaillie, Catherine M, Nienhuis, Arthur W, Wolfsberg, Tyra G, Dunbar, Cynthia E, and Calmels, Boris
- Subjects
SIMIAN immunodeficiency virus ,MOUSE leukemia viruses ,GENETIC transformation ,RHESUS monkeys ,PRIMATES - Abstract
Murine leukemia virus (MLV)-derived vectors are widely used for hematopoietic stem cell (HSC) gene transfer, but lentiviral vectors such as the simian immunodeficiency virus (SIV) may allow higher efficiency transfer and better expression. Recent studies in cell lines have challenged the notion that retroviruses and retroviral vectors integrate randomly into their host genome. Medical applications using these vectors are aimed at HSCs, and thus large-scale comprehensive analysis of MLV and SIV integration in long-term repopulating HSCs is crucial to help develop improved integrating vectors. We studied integration sites in HSCs of rhesus monkeys that had been transplanted 6 mo to 6 y prior with MLV- or SIV-transduced CD34
+ cells. Unique MLV (491) and SIV (501) insertions were compared to a set of in silico-generated random integration sites. While MLV integrants were located predominantly around transcription start sites, SIV integrants strongly favored transcription units and gene-dense regions of the genome. These integration patterns suggest different mechanisms for integration as well as distinct safety implications for MLV versus SIV vectors. A primate model of gene transfer into hematopoietic stem cells demonstrated MLV integration around transcription start sites whereas SIV integrated into gene-dense regions, indicating distinct safety implications for each. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
41. Efficient Characterization of Retro-, Lenti-, and Foamyvector-Transduced Cell Populations by High-Accuracy Insertion Site Sequencing.
- Author
-
SCHMIDT, MANFRED, GLIMM, HANNO, WISSLER, MANUELA, HOFFMANN, GESA, OLSSON, KARIN, SELLERS, STEPHANIE, CARBONARO, DENISE, TISDALE, JOHN F., LEURS, CORDULA, HANENBERG, HELMUT, DUNBAR, CYNTHIA E., KIEM, HANS-PETER, KARLSSON, STEFAN, KOHN, DONALD B., WILLIAMS, DAVID, and KALLE, CHRISTOF
- Published
- 2003
- Full Text
- View/download PDF
42. The Experience of a Native American English Professor in Central Pennsylvania.
- Author
-
Sellers, Stephanie
- Subjects
RACISM ,INDIGENOUS peoples of the Americas ,COLLEGE teachers ,UNIVERSITIES & colleges - Abstract
Describes the academic life of a Native American English professor at a wealthy college in Pennsylvania. Attitude of other faculty members toward the Nativeness of the professor; Goal of the professor; Racism experienced by the professor.
- Published
- 2003
- Full Text
- View/download PDF
43. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
- Author
-
Hubbard, Richard C., Brantly, Mark L., Sellers, Stephanie E., Mitchell, Marc E., Crystal, Ronald G., Hubbard, R C, Brantly, M L, Sellers, S E, Mitchell, M E, and Crystal, R G
- Subjects
DIAGNOSTIC use of aerosols ,ALPHA 1-antitrypsin ,AEROSOLS ,ALPHA 1-antitrypsin deficiency ,ANIMAL experimentation ,CLINICAL trials ,LUNGS ,NEUTROPHILS ,PERMEABILITY ,PROTEOLYTIC enzymes ,PULMONARY alveoli ,SHEEP ,CHEMICAL inhibitors - Abstract
Study Objective: To determine if aerosolization of purified human plasma alpha 1-antitrypsin is an effective means for increasing lower respiratory anti-neutrophil-elastase defenses in alpha 1-antitrypsin deficiency.Design: Nonrandomized, before-and-after trial with a 7-day treatment period. Companion studies in animals to determine lung epithelial permeability to alpha 1-antitrypsin.Patients: Twelve patients with homozygous Z-type alpha 1-antitrypsin deficiency and mild to moderate emphysema.Interventions: Aerosol administration of human plasma alpha 1-antitrypsin, 100 mg every 12 hours for 7 days. Single, 100-mg aerosol dose to anesthetized sheep with indwelling thoracic lymph duct catheters for direct assessment of lung permeability.Measurements and Main Results: Treatment resulted in increased alpha 1-antitrypsin levels in the lung epithelial lining fluid (0.28 +/- 0.07 microM before therapy to 5.86 +/- 1.03 microM after therapy) and increased anti-neutrophil-elastase capacity (0.78 +/- 0.38 microM before therapy to 4.16 +/- 0.95 microM after therapy). Aerosolized alpha 1-antitrypsin diffused across the respiratory epithelium and entered lung interstitial lymph (in sheep) and reached the systemic circulation (in sheep and humans). No side effects were noted.Conclusion: Short-term aerosol administration of human plasma alpha 1-antitrypsin to patients with alpha 1-antitrypsin deficiency is safe and feasible, resulting in a return to normal of anti-neutrophil-elastase defenses in the lower respiratory tract. The aerosol approach, therefore, merits serious long-term evaluation as an alternative to other parenteral forms of administering therapeutic proteins. [ABSTRACT FROM AUTHOR]- Published
- 1989
- Full Text
- View/download PDF
44. Mixed Valvular Disease Following Transcatheter Aortic Valve Replacement: Quantification and Systematic Differentiation Using Clinical Measurements and Image-Based Patient-Specific In Silico Modeling.
- Author
-
Keshavarz-Motamed, Zahra, Khodaei, Seyedvahid, Rikhtegar Nezami, Farhad, Amrute, Junedh M, Lee, Suk Joon, Brown, Jonathan, Ben-Assa, Eyal, Garcia Camarero, Tamara, Ruano Calvo, Javier, Sellers, Stephanie, Blanke, Philipp, Leipsic, Jonathon, de la Torre Hernandez, Jose M, and Edelman, Elazer R
- Published
- 2020
- Full Text
- View/download PDF
45. Indexed Aortic Area in Bicuspid Valve Disease: An Important Step Toward a More Personalized Approach to Risk Prediction and Clinical Decision Making.
- Author
-
Sellers, Stephanie L., Murphy, Darra T., and Leipsic, Jonathon A.
- Published
- 2017
- Full Text
- View/download PDF
46. Role of MDCT Imaging in Planning Mitral Valve Intervention.
- Author
-
Grover, Rominder, Ohana, Mickael, Arepalli, Chesnal Dey, Sellers, Stephanie L., Mooney, John, Kueh, Shaw-Hua, Kim, Ung, Blanke, Philipp, and Leipsic, Jonathon A.
- Abstract
Purpose of Review: Recent advancements in transcatheter valvular interventions have resulted in a growing demand for advanced cardiac imaging to help guide these procedures.Recent Findings: Both echocardiography and multi-detector computed tomography have played essential roles in the maturation of transcatheter aortic valve replacement and are now building on these experiences and helping inform the nascent field of transcatheter mitral interventions.Summary: Advanced imaging is essential to aid in the diagnosis and determination of the mechanism of mitral regurgitation. In addition, they are integral to annular sizing, determination of the suitability of patient anatomy for specific devices and increasingly important in the determination of the risk of left ventricular outflow tract obstruction and providing appropriate patient-specific fluoroscopic angulation in advance of the procedure. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
47. Characterizing and treating pulmonary pathology in Marfan syndrome (847.2).
- Author
-
Sellers, Stephanie, Chan, Rayleigh, Hirota, Jeremy, Mielnik, Michael, Hogg, James, and Bernatchez, Pascal
- Published
- 2014
- Full Text
- View/download PDF
48. Looking Good.
- Author
-
Sellers, Stephanie A.
- Abstract
A letter to the editor is presented which is concerned with images of women which are contained in issues of the periodical "Yoga Journal."
- Published
- 2011
49. Gathering Together: The Shawnee People through Diaspora and Nationhood, 1600-1870.
- Author
-
SELLERS, STEPHANIE A.
- Subjects
SHAWNEE (North American people) ,NONFICTION - Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.